Glover's Medicated Anti-Dandruff Scalp Solution

Manufacturer: J. Strickland & Co.
Effective date: 2023-10-21
Label type: HUMAN OTC DRUG LABEL
Version: 5
Source: full-release
Hydrated at: 2026-05-31 23:57:09

Label at a glance#

ProductGlovers Medicated Anti-Dandruff Scalp

Active ingredientSALICYLIC ACID

Label structure6 sections

Dosage and administration

Apply to the affected area one to four times daily or as directed by a doctor Use after shampooing or between shampoos.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid, 3%

Purposes

OTC - PURPOSE SECTION

Antidandruff,

Seborrheic Dermatitis,

Psoriasis

Use

INDICATIONS & USAGE SECTION

for relief of scalp itching, irritation, redness, scaling and flaking associated with dandruff, seborrheic dermatitis and psoriasis.

Warnings:

WARNINGS SECTION

For External Use Only.

Ask a doctor before use if

OTC - ASK DOCTOR SECTION

the condition covers a large area of the body

When using this product

OTC - WHEN USING SECTION

avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.

Stop use and ask a doctor if

OTC - STOP USE SECTION

condition worsens or does not improve after regular use of this product as directed.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or call a poison control center right away.

Flammable

SPL UNCLASSIFIED SECTION

Keep away from heat and open flame.

Directions:

DOSAGE & ADMINISTRATION SECTION

Apply to the affected area one to four times daily or as directed by a doctor
Use after shampooing or between shampoos.

Inactive Ingredients:

INACTIVE INGREDIENT SECTION

SD Alcohol 40, Water, Propylene Glycol, Benzyl Alcohol, Menthol.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

011-00011-01

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
251294	salicylic acid 3 % Topical Solution	PSN	5
251294	salicylic acid 30 MG/ML Topical Solution	SCD	5
251294	salicylic acid 3 % Topical Solution	SY	5

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
12022-011-00	Glovers Medicated Anti-Dandruff Scalp	1 in 1 CARTON	SOLUTION	1		5
12022-011-00	Glovers Medicated Anti-Dandruff Scalp	75 mL in 1 BOTTLE	SOLUTION	75		5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
12022-011	GLOVERS MEDICATED ANTI-DANDRUFF SCALP (SALICYLIC ACID) SOLUTION [J. STRICKLAND & CO.]	5	Current NDC, Legacy NDC, 2 package rows	20231021_bdf40a16-7b40-497e-939d-366cbe62b555.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

Glovers Medicated Anti-Dandruff Scalp
Salicylic Acid
WATER
PROPYLENE GLYCOL
BENZYL ALCOHOL
MENTHOL

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
12022-011	12022-011-00

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
WATER	059QF0KO0R	IACT
PROPYLENE GLYCOL	6DC9Q167V3	IACT
BENZYL ALCOHOL	LKG8494WBH	IACT
MENTHOL	L7T10EIP3A	IACT
SALICYLIC ACID	O414PZ4LPZ	ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Glovers Medicated Anti-Dandruff Scalp	SALICYLIC ACID	J. Strickland & Co.	bdf40a16-7b40-497e-939d-366cbe62b555	2023-10-21	Warnings	Exact identifier ndc (package): 12022-011-00 ndc (product): 12022-011 ndc11 (package): 12022001100 spl id: 083412a9-8755-f3ac-e063-6294a90af46a spl set id: bdf40a16-7b40-497e-939d-366cbe62b555

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.